Physician profile
Alek Mishail
NPI 1447421821
$8,048.96
in general payments reported to CMS, 2019-2025
33 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $275 · 2021: $754 · 2022: $1,406 · 2023: $1,812 · 2024: $1,566 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,756 · Education: $178 · Gift: $81.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,756.25 |
| Education | $178.35 |
| Gift | $81.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,442.56 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Sumitomo Pharma America, INC. | $1,050.10 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $693.08 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Teleflex LLC | $451.68 | 2021-2025 | Urolift |
| Abbvie INC. | $434.70 | 2022-2024 | |
| Boston Scientific Corporation | $432.24 | 2019-2024 | Rezum Generator |
| Coloplast Corp | $402.10 | 2019-2025 | Speedicath, Titan |
| Myovant Sciences INC. | $337.36 | 2021-2022 | |
| Tolmar, INC. | $325.45 | 2024-2025 | Jatenzo |
| Urovant Sciences INC | $311.80 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $298.23 | 2022-2025 | |
| Pfizer INC. | $254.10 | 2019-2025 | |
| Telix Pharmaceuticals | $214.43 | 2024-2025 | Illuccix |
| Dentsply Ih Ab | $142.84 | 2023-2025 | Lofric, Lofric |
| Neotract INC. | $142.59 | 2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $141.13 | 2020-2024 | Xiaflex, Aveed |
| Caldera Medical, INC | $126.57 | 2021-2023 | Desara |
| Antares Pharma, INC. | $126.30 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Endo USA, INC. | $102.25 | 2024-2025 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $80.78 | 2022-2025 | Posluma |
| Myriad Genetic Laboratories, INC. | $76.99 | 2021-2022 | |
| Olympus America INC. | $71.96 | 2025 | Itind System |
| Acerus Pharmaceuticals Corporation | $70.21 | 2022 | |
| Axonics, INC. | $69.94 | 2022-2024 | Bulkamid |
| Dentsply Ih INC. | $60.13 | 2019-2021 | |
| Clarus Therapeutics INC. | $40.98 | 2021 | |
| Calyxo, INC. | $36.94 | 2024 | Cvac Aspiration System |
| Ferring Pharmaceuticals INC. | $24.13 | 2019 | |
| Verity Pharmaceuticals INC. | $21.16 | 2022 | |
| 180 Medical, INC. | $18.91 | 2019 | |
| Halozyme INC | $16.10 | 2023 | |
| Abc Home Medical Supply, INC. | $15.61 | 2024 | |
| Hollister Incorporated | $15.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alek Mishail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.